Development of a nucleic acid lateral flow strip for detection of Hepatitis C virus (HCV) core antigen

Nucleosides, Nucleotides and Nucleic Acids

Volumn 32, Issue 2, 2013, Pages 59-68

  Wang, Chunfeng ^a   Zhang, Lianfeng ^a   Shen, Xuanmei ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b Zhoukou Central Hospital   (China)

Author keywords

Core antigen; Detection; HCV; Lateral flow strip; Nucleic acid aptamer

Indexed keywords

ANTIGEN P24; APTAMER; DNA; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; MONTIRELIN; UNCLASSIFIED DRUG;

ARTICLE; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; LIMIT OF DETECTION; NUCLEIC ACID LATERAL FLOW STRIP; SENSITIVITY AND SPECIFICITY; TEST STRIP; VIRUS DETECTION; VIRUS LOAD;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; LIMIT OF DETECTION; MOLECULAR SEQUENCE DATA; REAGENT STRIPS;

EID: 84874635917     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2013.763976     Document Type: Article

References (30)

1. Puoti, C.; Guarisco, R.; Bellis, L.; Spilabotti, L. Diagnosis, management, and treatment of hepatitis C. Hepatology 2009, 50(322), 324-325.
2. Irshad, M.; Ansari, M.A.; Singh, A.; Nag, P.; Raghvendra, L.; Singh, S.; Badhal, S.S. HCV-genotypes: A review on their origin, global status, assay system, pathogenecity and response to treatment. Hepatogastroenterology 2010, 57, 1529-1538.
3. Seme, K.; Poljak, M.; Babic, D.Z.; Mocilnik, T. Vince, A. The role of core antigen detection in management of hepatitis C: A critical review. J. Clin. Virol. 2005, 32, 92-101. (Pubitemid 40093959)
4. Schiff, E.R.; deMedina, M.; Kahn, R.S. New perspectives in the diagnosis of hepatitis C. Semin. Liver Dis. 1999, 19 Suppl 1, 3-15.
5. Gaudy, C.; Thevenas, C.; Tichet, J.; Mariotte, N.; Goudeau, A.; Dubois, F. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J. Clin. Microbiol. 2005, 43, 1722-1726.
6. Laperche, S.; Le Marrec, N.; Simon, N.; Bouchardeau, F.; Defer, C.; Maniez-Montreuil, M.; Levayer, T.; Zappitelli, J.P.; Lefrere, J.J. A new HCV core antigen assay based on disassociation of immune complexes: An alternative to molecular biology in the diagnosis of early HCV infection. Transfusion 2003, 43, 958-962. (Pubitemid 36753947)
7. Simmonds, P.; Kurtz, J.; Tedder, R.S. The UK blood transfusion service: Over a (patent) barrel? Lancet. 2002, 359, 1713-1714. (Pubitemid 34607081)
8. Mondelli, M.U. Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: Too early to take shortcuts? J. Hepatol. 2004, 40, 536-538. (Pubitemid 38230859)
9. Bouvier-Alias, M.; Patel, K.; Dahari, H.; Beaucourt, S.; Larderie, P.; Blatt, L.; Hezode, C.; Picchio, G.; Dhumeaux, D.; Neumann, A.U.; McHutchison, J.G.; Pawlotsky, J.M. Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication. Hepatology 2002, 36, 211-218. (Pubitemid 34700780)
10. Shi, H.; Hoffman, B.E.; Lis, J.T. RNA aptamers as effective protein antagonists in a multicellular organism. Proc. Natl. Acad. Sci. USA. 1999, 96, 10033-10038. (Pubitemid 29422507)
11. Famulok, M.; Blind, M.; Mayer, G. Intramers as promising new tools in functional proteomics. Chem. Biol. 2001, 8, 931-939. (Pubitemid 32918923)
12. Tuerk, C.; Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249, 505-510.
13. Jayasena, S.D. Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 1999, 45, 1628-1650. (Pubitemid 29419030)
14. Lee, S.; Kim, Y.S.; Jo, M.; Jin, M.; Lee, D.K.; Kim, S. Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen. Biochem. Biophys. Res. Commun. 2007, 358, 47-52. (Pubitemid 46719079)
15. Hayat, M.A. Colloidal Gold: Principles, Methods, and Applications, Academic Press, London, UK, 1989.
16. Mirkin, C.A.; Letsinger, R.L.;Mucic, R.C.; Storhoff, J.J.ADNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 1996, 382, 607-609. (Pubitemid 26268949)
17. Gu, S.; Liu, J.; Zhang, H.; Gu, B.; Lai, H.; Zhou, H.; He, C.; Chen, Y. Core antigen tests for hepatitis C virus: A meta-analysis. Mol. Biol. Rep. 2012, 39, 8197-8208.
18. Kuo, Y.H.; Chang, K.C.; Wang, J.H.; Tsai, P.S.; Hung, S.F.; Hung, C.H.; Chen, C.H.; Lu, S.N. Is hepatitis C virus core antigen an adequate marker for community screening? J. Clin. Microbiol. 2012, 50, 1989-1993.
19. Konno, K.; Iizuka, M.; Fujita, S.; Nishikawa, S.; Hasegawa, T.; Fukuda, K. An RNA aptamer containing two binding sites against the HCV minus-IRES domain I. Nucleos. Nucleotides Nucleic Acids. 2011, 30, 185-202.
20. Hwang, B.; Lim, J.H.; Hahm, B.; Jang, S.K.; Lee, S.W. hnRNP L is required for the translation mediated by HCV IRES. Biochem. Biophys. Res. Commun. 2009, 378, 584-588.
21. Kikuchi, K.; Umehara, T.; Nishikawa, F.; Fukuda, K.; Hasegawa, T.; Nishikawa, S. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES. Biochem. Biophys. Res. Commun. 2009, 386, 118-123.
22. Bellecave, P.; Cazenave, C.; Rumi, J.; Staedel, C.; Cosnefroy, O.; Andreola, M.L.; Ventura, M.; Tarrago-Litvak, L.; Astier-Gin, T. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: Mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells. Antimicrob. Agents. Chemother. 2008, 52, 2097-2110. (Pubitemid 351758547)
23. Fukuda, K.; Toyokawa, Y.; Kikuchi, K.; Konno, K.; Ishihara, R.; Fukazawa, C.; Nishikawa, S.; Hasegawa, T. Isolation of RNA aptamers specific for the 3' X tail of HCV. Nucleic Acids Symp. Ser. (Oxf). 2008,205-206.
24. Frick, D.N. The hepatitis C virus NS3 protein: A model RNA helicase and potential drug target. Curr. Issues Mol. Biol. 2007, 9, 1-20. (Pubitemid 46139067)
25. Wang, X.; Li, K.; Shi, D.; Xiong, N.; Jin, X.; Yi, J.; Bi, D. Development of an immunochromatographic lateral-flow test strip for rapid detection of sulfonamides in eggs and chicken muscles. J. Agric. Food Chem. 2007, 55, 2072-2078. (Pubitemid 46556187)
26. Liu, B.; Tsao, Z.; Wang, J.; Yu, F. Development of a monoclonal antibody against ochratoxin a and its application in enzyme-linked immunosorbent assay and gold nanoparticle immunochromatographic strip. Anal. Chem. 2008, 80, 7029-7035.
27. Zhang, G.; Wang, X.; Zhi, A.; Bao, Y.; Yang, Y.; Qu, M.; Luo, J.; Li, Q.; Guo, J.; Wang, Z.; Yang, J.; Xing, G.; Chai, S.; Shi, T.; Liu, Q. Development of a lateral flow immunoassay strip for screening of sulfamonomethoxine residues. Food Addit. Contam. Part A Chem. Anal Control Expo. Risk Assess. 2008, 25, 413-423. (Pubitemid 351420239)
28. Rheeder, J.P.; Marasas, W.F.; Vismer, H.F. Production of fumonisin analogs by Fusarium species. Appl. Environ. Microbiol. 2002, 68, 2101-2105. (Pubitemid 34477801)
29. Mikawa, A.Y.; Santos, S.A.; Kenfe, F.R.; Da, S.F.; Da, C.P. Development of a rapid one-step immunochromatographic assay for HCV core antigen detection. J. Virol. Methods. 2009, 158, 160-164.
30. Valcavi, P.; Medici, M.C.; Casula, F.; Arcangeletti, M.C.; De Conto, F.; Pinardi, F.; Calderaro, A.; Chezzi, C.; Dettori, G. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. J. Med. Virol. 2004, 73, 397-403. (Pubitemid 38685747)